Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06436612 · ClinicalTrials.gov registry record · Phase 2
Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdominopelvic Sarcomas (MARS Trial)
A Phase 2 study of Abdominopelvic Sarcomas, sponsored by Jonsson Comprehensive Cancer Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06436612 is a Phase 2 study of Abdominopelvic Sarcomas that is actively recruiting participants, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06436612, a Phase 2 study of Abdominopelvic Sarcomas, is actively recruiting participants, sponsored by Jonsson Comprehensive Cancer Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Recent advances in radiation treatment have allowed for higher doses per treatment to be delivered safely. This study plans to use an MRI-guided linear accelerator to deliver the radiation treatment to ensure that the radiation dose is administered to the cancerous tumor, not the vital body organs. Potential participants with a sarcoma diagnosis will be referred to Radiation Oncology during this study. If the participant is interested in participating in this study, s/he receives radiation treatment daily for 5 consecutive days except for weekends and holidays. Within 12 weeks of completing the radiation therapy, the participant will have the primary tumor surgically removed. The radiation oncology team will follow the patients for 5 years after completing radiation therapy.
Conditions Studied
Interventions
- RADIATION Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy
Study Locations (1)
California
- UCLA / Jonsson Comprehensive Cancer Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-05-30 |
| Est. Completion | 2028-05-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06436612
The ClinicalTrials.gov registry entry for NCT06436612 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abdominopelvic Sarcomas appearing as the primary indexed condition, and to 1 intervention - of which Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy is the first listed.
NCT06436612 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06436612 about?
NCT06436612 is a clinical study titled "Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdominopelvic Sarcomas (MARS Trial)". Recent advances in radiation treatment have allowed for higher doses per treatment to be delivered safely. This study plans to use an MRI-guided linear accelerator to deliver the radiation treatment to ensure that the radiation dose is administered to the cancerous tumor, not the vital body organs. ...
What is the current status of trial NCT06436612?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2024-05-30. Estimated completion is 2028-05-26.
What conditions does trial NCT06436612 study?
This clinical trial studies the following conditions: Abdominopelvic Sarcomas.
What interventions are being tested in trial NCT06436612?
The interventions under investigation include: Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT06436612?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06436612 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.